ICM
GILD icon

Islay Capital Management’s Gilead Sciences GILD Stock Holding History

Islay Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,708
Closed -$102K – 294
2022
Q1 		$102K Buy
+1,708
New +$109K 0.08% 146
2021
Q4 		– Sell
-1,741
Closed -$122K – 292
2021
Q3 		$122K Sell
1,741
-35
-2% -$2.46K 0.09% 123
2021
Q2 		$122K Buy
+1,776
New +$119K 0.1% 112

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Islay Capital Management's GILD Position: Q2 2022 in Review

Islay Capital Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 1,708 shares — an estimated $102K sold.

Islay Capital Management first reported a position in GILD in Q2 2021 and held it in 3 quarters. The position peaked at $122K in Q3 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Islay Capital Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Islay Capital Management sold 1,708 Gilead Sciences shares in Q2 2022, an estimated $102K.
  • Islay Capital Management first reported a position in Gilead Sciences in Q2 2021 and held it in 3 quarters.
  • Islay Capital Management's Gilead Sciences position peaked at $122K in Q3 2021.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Islay Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.